Health Conditions Recommended for:

New Balance 870v3 Running Shoes

Item #: 89075
100% of customers would recommend this to a friend (3 out of 3)
UNFORTUNATELY, THIS PRODUCT IS CURRENTLY UNAVAILABLE.

For an alternate suggestion, see featured items on the right.

  • Orthotic-Friendly.
Share with friends
  • Pinterest

New Balance Women's 870v3 Running Shoes offer a real down-to-earth comfort experience in a low-profile design

Lowering the heel to keep the foot closer to the ground is not only a more natural way to run and walk, it helps enhance stability. That’s why you’ll love the low profile of this running shoe from New Balance. The natural PL-1 last (shape) promotes a more natural foot strike. The REVlite® midsole provides lightweight cushioning and durability, while the removable ABZORB® foam insole delivers even more cushioned comfort. Recommended for normal arch foot types. Orthotic-Friendly.

Features & Benefits of New Balance 870v3 Running Shoes:

  • Low-profile, natural PL-1 last (shape) positions the heel 8mm higher than the forefoot for a more natural foot strike.
  • Synthetic / thermoplastic polyurethane upper with no-sew seamless construction offers lightweight comfort.
  • Innovative, lightweight REVlite foam midsole provides the same cushioning and durability as heavier foams.
  • Ndurance rubber delivers maximum durability in high-wear areas of the outsole.
  • Removable ABZORB top-of-the-line foam insole adds extra cushioning.

Other Important Information About New Balance 870v3 Running Shoes:

  • Material Content: synthetic / thermoplastic polyurethane upper, nylon upper lining and sockliner, ABZORB insole, REVlite midsole, blown rubber / Ndurance rubber outsole.
  • Care: Wipe off with a damp cloth. Air dry.
  • Imported.

About New Balance: 

New Balance strives to help people meet their fitness goals, whether it’s living a more healthy and active lifestyle or walking or running a first 5K. New Balance footwear blends function and fashion, offering performance technology with sporty style.